Hologic Inc (HOLX) Files Form 4 Insider Selling : Lawrence M Levy Sells 17,794 Shares

Hologic Inc (HOLX): Lawrence M Levy , director of Hologic Inc sold 17,794 shares on Jun 1, 2016. The Insider selling transaction was reported by the company on Jun 2, 2016 to the Securities and Exchange Commission. The shares were sold at $34.41 per share for a total value of $612,327.12 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 31, 2016, Peter J. Iii Valenti (Division Pres., Breast Health) sold 10,022 shares at $33.84 per share price.On May 31, 2016, Karleen Marie Oberton (Corp. VP & Chief Acctg Officer) sold 4,228 shares at $33.85 per share price.Also, On May 31, 2016, Elaine Ullian (director) sold 6,896 shares at $33.85 per share price.On Feb 26, 2016, David R Jr Lavance (director) sold 11,621 shares at $34.50 per share price.

Hologic: On Wednesday, Jun 1, 2016 heightened volatility was witnessed in Hologic which led to swings in the share price. The shares opened for trading at $34.27 and hit $34.73 on the upside , eventually ending the session at $34.66, with a gain of 0.73% or 0.25 points. The heightened volatility saw the trading volume jump to 34,63,390 shares. The 52-week high of the share price is $43 and the company has a market cap of $9,664 M . The 52-week low of the share price is at $31.84.

Hologic Money Flow Index Chart

Company has been under the radar of several Street Analysts.Hologic is Downgraded by Needham to Hold. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Apr 28, 2016.

Hologic Inc. is a developer manufacturer and supplier of diagnostics products medical imaging systems and surgical products. The Company’s business units are focused on diagnostics breast health GYN surgical and skeletal health. The Company’s diagnostics products include Aptima family of assays its ThinPrep system the Rapid Fetal Fibronectin Test and its Procleix blood screening assays. The Aptima family of assays is used to detect the infectious microorganisms that cause the common sexually transmitted diseases chlamydia and gonorrhea certain high-risk strains of human papillomavirus (HPV) and Trichomonas vaginalis the parasite that causes trichomoniasis. The Company’s GYN surgical products include its NovaSure Endometrial Ablation System and its MyoSure Hysteroscopic Tissue Removal System. The skeletal health products include dual-energy X-ray bone densitometry systems an ultrasound-based osteoporosis assessment product and its Fluoroscan mini C-arm imaging products.

Leave a Reply

Hologic - Is it time to Sell?

Top Brokerage Firms are advising their investors on Hologic. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.